ME

Companies
NASDAQ
23andMe Holding Co.
Health Care
Price Chart
Overview

About ME

23andMe Holding Co is a consumer-facing healthcare technology company, primarily involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail. The company provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic trait reports, and various health predisposition and disease carrier reports. Its segment includes Consumer and Research Services and Therapeutics. The company generates maximum revenue from the Consumer and Research Services segment.

Market Cap
$198.1M
Volume
2.6M
Avg. Volume
1.4M
P/E Ratio
-0.011888235
Dividend Yield
0.00%
Employees
719.0

Company Information

Exchange
NASDAQ
Sector
Health Care
Industry
Diagnostics & Research
Risk & Correlation Analysis
Market Correlation
1.44
High Correlation
Volatility
High (0.99)
Relative to market

Macro Factor Sensitivities

Interest Rates
Low Sensitivity
Inflation
High Sensitivity
GDP Growth
High Sensitivity
Liquidity
High Sensitivity
Commodity Prices
High Sensitivity
Credit Quality
Medium Sensitivity
Portfolio Impact
Forecasts & Predictions

Premium Forecasts

Get AI-powered price predictions, technical analysis, and market forecasts for ME.

1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential

Technical Analysis

Based on technical indicators and chart patterns, ME shows...

AI Sentiment Analysis

Market sentiment analysis indicates...

Key Statistics
Market Cap$198.1M
Volume2.6M
P/E Ratio-0.01
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
August 9, 2023

PortfolioPilot Analysis

Get AI-powered insights on how ME fits into your investment strategy and portfolio diversification.

Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025